NCT07378748Completed
Effect of Bedtime Mindfulness Meditation on Anxiety and Spiritual Well-Being in Hemodialysis Patients
Effect of Bedtime Meditation on Spiritual Well-Being and Anxiety in Hemodialysis Patients
Source: ClinicalTrials.gov · Last updated 30 Jan 2026
Brief summary (registry, in English)
This study evaluates whether Bedtime Meditation Based on Mindfulness (BM-BOM) can reduce anxiety and improve spiritual well-being in patients undergoing hemodialysis. People receiving long-term hemodialysis often experience emotional stress, anxiety, and spiritual distress due to chronic illness, treatment burden, and lifestyle limitations. These problems may affect their quality of life and overall well-being. Mindfulness meditation is a simple, low-cost, and safe non-drug approach that may help patients feel calmer, more focused, and more spiritually connected. In this study, adult hemodialysis patients are randomly assigned to one of two groups. The intervention group receives a guided mindfulness meditation program. Participants attend a single 2.5-hour training session led by a certified mindfulness instructor and then practice guided meditation during their hemodialysis sessions twice a week for four weeks using audio recordings. Each session lasts approximately 15 minutes and includes breathing awareness, body awareness, and short reflection. The control group follows the same schedule and duration but rests quietly with eyes closed without guided meditation. Participants complete questionnaires before and after the four-week program to measure anxiety and spiritual well-being. The results of this study will help determine whether guided mindfulness meditation can be used as a practical and supportive complementary therapy for patients receiving hemodialysis.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 58 (actual)
- First submitted
- 23 Jan 2026
- Start date
- 1 Jun 2025
- Primary completion date
- 30 Jul 2025
- Lead sponsor
- Universitas Muhammadiyah Surakarta
- Diseases
- Chronic kidney disease
- NCT number
- NCT07378748
What you commit to
- Study type: Interventional
- Participants enrolled: 58
- From 1 Jun 2025 to the primary completion date, 30 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe cognitive impairment.
- Diagnosed psychological or psychiatric disorders.
- Any medical condition that prevents participation in the mindfulness intervention.
Who the study is looking for
- Diagnosed with chronic kidney disease (CKD) stage V.
- Undergoing outpatient hemodialysis for at least three months.
- Aged 18 years or older.
- Able to communicate effectively.
- Willing to participate and provide written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UNS Hospital Coordinator of this site? Confirm its status | Surakarta | Indonesia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.